reviewTop 10% cited
HDAC expression and clinical prognosis in human malignancies
Cancer Letters · 2008 · Vol. 280(2) · pp. 168–176
Wilko Weichert✉(Charité - Universitätsmedizin Berlin)
Histone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsEpigenetics and DNA MethylationHistone deacetylaseHistoneGene isoformCancer researchHDAC11VorinostatBiologyHistone deacetylase inhibitorHistone deacetylase 5HDAC10
MeSH terms
Antineoplastic AgentsHistone DeacetylasesHumansIsoenzymesNeoplasmsOrgan SpecificityPrognosisBiomarkers, Tumor
Citations
418
FWCI
7.45
field-weighted impact
References
71
Percentile
98%
vs. same field & year
Citations per year
References
Anticancer activities of histone deacetylase inhibitors
Nature Reviews Drug Discovery · 2006 · 2,905 citations
Histone deacetylases and cancer
Oncogene · 2007 · 1,039 citations
Acetylation and deacetylation of non-histone proteins
Gene · 2005 · 1,568 citations
Histone deacetylase inhibitors: molecular mechanisms of action
Oncogene · 2007 · 1,533 citations
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*
Breast Cancer Research and Treatment · 2005 · 306 citations
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Nature reviews. Cancer · 2006 · 2,190 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.